Publication | Closed Access

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

Pulmonary TuberculosisTreatment And PreventionRandomised TrialTuberculosis PreventionAntiviral TherapyReflate TbTuberculosisChronic Viral InfectionAntiviral DrugHivPhase 2Medicine